Allergan's second-quarter revenues were down by 0.8 percent to $4,090...

Allergan's second-quarter revenues were down by 0.8 percent to $4,090 million, but increased by 1.2 percent on a currency-neutral basis. The operating loss widened to $1,263 million from $467.0 million a year earlier due to impairment charges. On an adjusted basis, the group posted operating income of $1,850 million, down ...

You need to register to continue reading this article

Already subscribe to Eyewear intelligence? Sign in here

Register to continue reading

By registering today you will have access to:

  • 3 industry news articles per month

For full access and to receive in-depth news, analysis and more, become a member today

For more content and resources become a member? View our membership packages.